Business Context and Reporting Period
This Form 8-K filing by MiMedx Group, Inc. (the "Company") reports a corporate governance event dated March 18, 2020. The filing announces the appointment of a new Chief Financial Officer (CFO) effective March 18, 2020, and the conclusion of the interim tenure of the previous acting CFO.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. This report focuses exclusively on executive compensation and personnel changes.
Material Changes
The primary material change is the leadership transition in the finance function:
- Appointment: Peter M. Carlson was appointed Chief Financial Officer, effective March 18, 2020.
- Departure: Edward J. Borkowski ceased serving as acting Chief Financial Officer on March 17, 2020. Mr. Borkowski had served as Interim CFO since June 2018 and acting CFO since November 2019.
- Background: Mr. Carlson previously served as the Company's Executive Vice President - Finance since December 2019. His prior experience includes roles at Brighthouse Financial, MetLife, and Wachovia Corporation.
Compensatory Arrangements and Outlook
The filing details the specific compensatory arrangements for Mr. Carlson, which include:
- Base Salary: $525,000 annually.
- Annual Incentive: Target of 55% of base salary.
- Long-Term Incentive: Target of 200% of base salary.
- Signing Bonus: One-time payment of $50,000, subject to full repayment if employment terminates within 12 months.
- Restricted Stock Grants:
- $350,000 value, vesting pro rata annually over three years.
- $1,000,000 value, vesting upon achievement of four discrete performance goals.
The filing states there are no family relationships between Mr. Carlson and other directors or officers, and no undisclosed arrangements regarding his selection.
Investor Verification Checklist
- Verify the vesting schedule and specific performance goals for the $1,000,000 restricted stock grant.
- Confirm the repayment terms for the $50,000 signing bonus in the event of early termination.
- Review the attached press release (Exhibit 99.1) for additional strategic context regarding the leadership change.
- Note that this filing contains no financial performance data; refer to the most recent 10-Q or 10-K for financial metrics.